Díez‐Campelo, M., Lorenzo, J. I., Itzykson, R., Rojas, S. M., Berthon, C., Luño, E., Beyne‐Rauzy, O., Perez‐Oteyza, J., Vey, N., Bargay, J., Park, S., Cedena, T., Bordessoule, D., Muñoz, J. A., Gyan, E., Such, E., Visanica, S., López‐Cadenas, F., de Botton, S., Hernández‐Rivas, J. M., Ame, S., Stamatoullas, A., Delaunay, J., Salanoubat, C., Isnard, F., Guieze, R., Pérez Guallar, J., Badiella, L., Sanz, G., Cañizo, C., & Fenaux, P. (2018). azacitidine improves outcome in higher‐risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries. British journal of haematology, 181, 350–359. http://access.bl.uk/ark:/81055/vdc_100060698517.0x00005c